APA (7th ed.) Citation

Konté, K., Afzali‐Hashemi, L., Baas, K., Schrantee, A., Nur, E., Nederveen, A., & Biemond, B. (2023). S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY. HemaSphere, 7(S3), e53603b7-n/a. https://doi.org/10.1097/01.HS9.0000968028.53603.b7

Chicago Style (17th ed.) Citation

Konté, Kadère, Liza Afzali‐Hashemi, Koen Baas, Anouk Schrantee, Erfan Nur, Aart Nederveen, and Bart Biemond. "S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY." HemaSphere 7, no. S3 (2023): e53603b7-n/a. https://doi.org/10.1097/01.HS9.0000968028.53603.b7.

MLA (9th ed.) Citation

Konté, Kadère, et al. "S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY." HemaSphere, vol. 7, no. S3, 2023, pp. e53603b7-n/a, https://doi.org/10.1097/01.HS9.0000968028.53603.b7.